These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6967756)

  • 41. Inhibition of graft rejection by LPS: further evidence for effects on T lymphocytes.
    Winchurch RA; Hilberg C; Birmingham W; Munster AM
    J Reticuloendothel Soc; 1982 Jan; 31(1):31-42. PubMed ID: 6977643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cellular immunity in mouse plasmocytomas].
    Lespinats G; Poupon MF
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):755-65. PubMed ID: 5050876
    [No Abstract]   [Full Text] [Related]  

  • 43. Proliferation of spleen cells in culture stimulated by 7-thia-8-oxoguanosine: evidence that both B- and T-cells are the targets of its action.
    Colic M; Vucevic D; Vasilijic S; Popovic L; Pejanovic V; Jandric D; Medic-Mijacevic L; Rakic L
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):583-90. PubMed ID: 10669901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selectivity of inhibition by anticancer agents of mouse spleen immune effector functions involved in responses to sheep erythrocytes.
    Ehrke MJ; Cohen SA; Mihich E
    Cancer Res; 1978 Mar; 38(3):521-30. PubMed ID: 626958
    [No Abstract]   [Full Text] [Related]  

  • 45. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
    Zhou J; Chen J; Zhong R; Mokotoff M; Shultz LD; Ball ED
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2224-31. PubMed ID: 16609038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Naturin: a potent bio-immunomodifier in experimental studies and clinical trials.
    Shen RN; Lu L; Jia XQ; Wong ML; Kaiser HE
    In Vivo; 1996; 10(2):201-9. PubMed ID: 8744801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunomodulatory activity of polysaccharides isolated from Strongylocentrotus nudus eggs.
    Liu C; Xi T; Lin Q; Xing Y; Ye L; Luo X; Wang F
    Int Immunopharmacol; 2008 Dec; 8(13-14):1835-41. PubMed ID: 18834960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Halothane-induced suppression of cell-mediated immunity in normal and tumor-bearing C3Hf/He mice.
    Lewis RE; Cruse JM; Hazelwood J
    Anesth Analg; 1980 Sep; 59(9):666-71. PubMed ID: 7191225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective antitumor immunity induced by immunization with completely allogeneic tumor cells.
    Toes RE; Blom RJ; van der Voort E; Offringa R; Melief CJ; Kast WM
    Cancer Res; 1996 Aug; 56(16):3782-7. PubMed ID: 8706024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional cytotoxic T lymphocyte hybridomas.
    Kaufmann Y; Berke G; Eshhar Z
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1170-4. PubMed ID: 6973859
    [No Abstract]   [Full Text] [Related]  

  • 52. Suppression of cell-mediated antitumor immunity by complete Freund's adjuvant.
    Koyama S; Yoshioka T; Sakita T
    Cancer Res; 1982 Aug; 42(8):3215-9. PubMed ID: 6980047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of anticancer drugs on the immune system in humans.
    Ehrke MJ; Mihich E; Berd D; Mastrangelo MJ
    Semin Oncol; 1989 Jun; 16(3):230-53. PubMed ID: 2658084
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of 2,7-bis(2-diethylamino)ethoxy)fluoren-9-one dihydrochloride (Tilorone) upon cell-mediated immunity in mice.
    Friedlaender GE; Mosher MB; Mitchell MS
    Cancer Res; 1974 Feb; 34(2):304-7. PubMed ID: 4544018
    [No Abstract]   [Full Text] [Related]  

  • 55. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.
    Bhattacharyya S; Mandal D; Sen GS; Pal S; Banerjee S; Lahiry L; Finke JH; Tannenbaum CS; Das T; Sa G
    Cancer Res; 2007 Jan; 67(1):362-70. PubMed ID: 17210719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of host immunity with 5-fluorouracil-initiated cure of plasmacytoma LPC-1 in BALB/c mice.
    Teller MN; Faanes RB
    Cancer Res; 1980 Aug; 40(8 Pt 1):2790-5. PubMed ID: 6966969
    [No Abstract]   [Full Text] [Related]  

  • 57. Release of a non-specific cytotoxic factor by splenic cells immunized against allogeneic tumour cells.
    Hottier D; Donner M; Burg C
    Rev Eur Etud Clin Biol; 1971 Mar; 16(3):240-3. PubMed ID: 5104840
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparative evaluation of the antitumor, cytogenetic and immunodepressive effects of dimetinur when used perorally and parenterally].
    Osatrovskaia LA; Fomina MM; Bogoslovskaia EP; Potapov SL; Korman DB
    Eksp Onkol; 1988; 10(6):44-8. PubMed ID: 3243195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stimulatory effects of vitamin A analogs on induction of cell-mediated cytotoxicity in vivo.
    Lotan R; Dennert G
    Cancer Res; 1979 Jan; 39(1):55-8. PubMed ID: 761198
    [No Abstract]   [Full Text] [Related]  

  • 60. Enhanced cell mediated immunity in mice after cisplatin treatment.
    Bahadur A; Sarna S; Sodhi A
    Pol J Pharmacol Pharm; 1984; 36(5):441-8. PubMed ID: 6543466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.